(*) USA Approval: 2017. 04.29. (2)
(*) USA Approval: 2020. 05.22. (1)
(1): 1st Line Treat.
(2): 2nd Line Treat.>Crizotinib
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 10.23.
TradeMark
TradeMark Web-Site